PAUL BROWN: Open Payments
NPI 1649682428 · HURON, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 13 payments from 4 companies in 2025. Trend: 2023 $141 · 2024 $130 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $151 |
| Novo Nordisk Inc | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: VRAYLAR, UBRELVY, Ozempic, QULIPTA, Veozah, NURTEC ODT.
Industry payments across SD — which companies pay providers there.
